Novo Nordisk's pre-market decline narrowed to 20%, with a previous drop of nearly 30% being the largest single day decline on record
六月清晨搅
发表于 어제 20:34
113
0
0
According to AI News, on December 20th, the pre-market decline of Novo Nordisk's US stock market narrowed to 20%, after a previous drop of nearly 30%, the largest single day decline on record, as the trial results of Novo Nordisk's weight loss drug CagriSema did not meet expectations.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Meta announces the establishment of a new artificial intelligence model, MovieGen, in the top 20 US stock market transactions
- TSMC Radio's stock fell more than 3%, marking the largest decline in over two weeks
- Top 20 US Stock Exchange Transactions: TSMC Increases Over 9%, Market Value Exceeds $1 Trillion
- US stocks close down: Nasdaq falls more than 2%, large tech stocks generally decline
- After the US election, Tesla's stock price surged by nearly 15%. Elon Musk's net worth increased by $20.9 billion in a single day
- Tesla: Nevada Gigafactory produces over 1000 units of household energy storage system Powerwall in a single day
- Supermicro Computer's US stock rose 40% after closing, as it submitted a compliance plan to NASDAQ
- Pinduoduo's pre-market decline widens to 13%
- Top 20 US Stock Transactions: Adobe's Poor Performance, Stock Price Falls 13.7%
- Novo Nordisk's pre-market decline narrows to 20%
-
"우리는 안전, 깨끗함, 유구한 역사, 인민 우호, 맛있는 음식 등이 외국 관광객들이 중국에 대해 기억하는 고주파 단어라는 것을 조사 연구했다."12월 18일 씨트립그룹은 아랍에미리트 아부다비에서 글로벌 파트너 ...
- 月六日尘
- 그저께 09:35
- Up
- Down
- Reply
- Favorite
-
12월 18일, 중국국가약품감독관리국은 EliLillyandCompany (이하"예래"로 략칭함.) 의 알츠하이머병요법을 비준하고 기능달 & amp;reg;(도네 단항 주사액, 4주마다 정맥 주입) 성인이 알츠하이머병으로 인한 경도 ...
- 我是来围观的逊
- 3 일전
- Up
- Down
- Reply
- Favorite
-
"푸틴은 방금 통화팽창이 걱정스럽다고 인정했지만 뜻밖에 금리인상을 중지했다."현지시간으로 금요일 (12월 20일), 로씨야중앙은행이 기준금리를 21% 로 유지한다고 선포했는데 이는 시장을 놀라게 했다. 투자자들 ...
- 瑜珈
- 4 시간전
- Up
- Down
- Reply
- Favorite
-
증권시보에 따르면 골드만삭스는 폭스(FOX) 목표주가를 51달러에서 57달러로 올리고 매수 등급을 유지했다. 여러 기관은 폭스사에 대해 낙관적이다. UBS는 한 보고서에서 기록적인 정치 주기와 강력한 스포츠 경기 ...
- 度素告
- 어제 09:27
- Up
- Down
- Reply
- Favorite